Dermapharm: latest news - GoINPHARMA
Sunday, 24 March 2019 - 18:33

Dermapharm

Disappointing debut for Dermapharm: -9%

Germany-based Dermapharm has not had the best debut at Frankfurt Stock Exchange. The company had been valued 29 euros per share, yet it soon declined by 9% on its debut day and fetched the Beier family–who owns almost all of…

Dermapharm confirms IPO and chooses Frankfurt stock exchange

Germany-based OTC manufacturer Dermapharm has confirmed today it plans to be listed before June 2018. Shareholders have chosen Frankfurt stock exchange for the IPO, in order to list 25% of the holding, and have decided to increase the company’s capital…

Dermapharm targets $1bn IPO before end of quarter

Reuters yesterday reported that the German group Dermapharm is planning an IPO as early as the end of the quarter. The offer will be worth approximately €1bn. Dermapharm was sold by its owner in 2016, but it was withdrawn since…

Dermapharm reportedly considering listing

Dermapharm is reportedly planning to try at an IPO as the attempt at divesting the group owned by its founder Wihlem Beier has failed. Indeed, Beier has recently received two offers by BC Partners and Nordic Capital. The two funds…

Dermapharm acquires Riemser’s Medical Devices business

Germany-based pharmaceutical group Dermapharm, specialized in antiallergic drugs and dermatology products, today announced it has acquired Riemser Pharma’s Medical Devices business. Riemser is a German pharmaceutical group owned by PE Ardian since 2012. The acquiree has a product portfolio including…